Literature DB >> 35226010

The fast-growing field of photo-driven theranostics based on aggregation-induced emission.

Zhijun Zhang1, Miaomiao Kang1, Hui Tan2, Nan Song1, Meng Li1, Peihong Xiao1, Dingyuan Yan1, Liping Zhang2, Dong Wang1, Ben Zhong Tang3.   

Abstract

Photo-driven theranostics, also known as phototheranostics, relying on the diverse excited-state energy conversions of theranostic agents upon photoexcitation represents a significant branch of theranostics, which ingeniously integrate diagnostic imaging and therapeutic interventions into a single formulation. The combined merits of photoexcitation and theranostics endow photo-driven theranostics with numerous superior features. The applications of aggregation-induced emission luminogens (AIEgens), a particular category of fluorophores, in the field of photo-driven theranostics have been intensively studied by virtue of their versatile advantageous merits of favorable biocompatibility, tuneable photophysical properties, unique aggregation-enhanced theranostic (AET) features, ideal AET-favored on-site activation ability and ready construction of one-for-all multimodal theranostics. This review summarised the significant achievements of photo-driven theranostics based on AIEgens, which were detailedly elaborated and classified by their diverse theranostic modalities into three groups: fluorescence imaging-guided photodynamic therapy, photoacoustic imaging-guided photothermal therapy, and multi-modality theranostics. Particularly, the tremendous advantages and individual design strategies of AIEgens in pursuit of high-performance photosensitizing output, high photothermal conversion and multimodal function capability by adjusting the excited-state energy dissipation pathways are emphasized in each section. In addition to highlighting AIEgens as promising templates for modulating energy dissipation in the application of photo-driven theranostics, current challenges and opportunities in this field are also discussed.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35226010     DOI: 10.1039/d1cs01138c

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  6 in total

1.  Novel Lysosome-Targeting Fluorescence Off-On Photosensitizer for Near-Infrared Hypoxia Imaging and Photodynamic Therapy In Vitro and In Vivo.

Authors:  Shangli Ding; Mingyan Yang; Jiajia Lv; Hongyu Li; Gang Wei; Jie Gao; Zeli Yuan
Journal:  Molecules       Date:  2022-05-27       Impact factor: 4.927

2.  A cell membrane-targeting AIE photosensitizer as a necroptosis inducer for boosting cancer theranostics.

Authors:  Niu Niu; Ying Yu; Zhijun Zhang; Miaomiao Kang; Lei Wang; Zheng Zhao; Dong Wang; Ben Zhong Tang
Journal:  Chem Sci       Date:  2022-04-19       Impact factor: 9.969

3.  J-aggregates albumin-based NIR-II fluorescent dye nanoparticles for cancer phototheranostics.

Authors:  Bulin Du; Ruiqi Liu; Chunrong Qu; Kun Qian; Yongkuan Suo; Fengxia Wu; Hongda Chen; Xuena Li; Yaming Li; Hongguang Liu; Zhen Cheng
Journal:  Mater Today Bio       Date:  2022-08-07

4.  Fibrous aggregates: Amplifying aggregation-induced emission to boost health protection.

Authors:  Zhenduo Qiu; Xiaoxiao Yu; Junyan Zhang; Chengjian Xu; Mengyue Gao; Yanhua Cheng; Meifang Zhu
Journal:  Biomaterials       Date:  2022-07-04       Impact factor: 15.304

5.  Conformationally Confined Emissive Cationic Macrocycle with Photocontrolled Organelle-Specific Translocation.

Authors:  Xiaoyun Dong; Xianyin Dai; Guorong Li; Ying-Ming Zhang; Xiufang Xu; Yu Liu
Journal:  Adv Sci (Weinh)       Date:  2022-06-17       Impact factor: 17.521

Review 6.  Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.

Authors:  Shun Luo; Shuijie Qin; Gerile Oudeng; Li Zhang
Journal:  Nanomaterials (Basel)       Date:  2022-08-31       Impact factor: 5.719

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.